IFPMA
From Wikipedia, the free encyclopedia
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is a global non-profit NGO representing research-based pharmaceutical, biotech and vaccine companies and national industry associations in developed and developing countries.[1]
Contents |
[edit] H5N1
The H5N1 pandemic threat has caused a vast increase in funding to influenza research.
The IFPMA's research-based vaccine manufacturing members are conducting a growing number of clinical trials of 'prototype' influenza vaccines, designed to counter to the threats of avian and pandemic influenza.[2]
[edit] See also
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Japan Pharmaceutical Manufacturers Association (JPMA)
- Pharmaceutical Research and Manufacturers of America (PhRMA)
- Pharmaceutical company
- Food and Drug Administration (FDA, USA)
- European Medicines Agency (EMEA)
- MedDRA
- H5N1 clinical trials
- International Society for Pharmaceutical Engineering
- International Pharmaceutical Excipients Council
[edit] Notes
- ^ Medical News Today article WHO Commission Report On Biomedical Innovation, Patents And Public Health Contains Many Sound Proposals - But Underestimates Vital Role Of Patents published April 5, 2006
- ^ Medical News Today article There Are Thirty-One Avian & Pandemic Prototype Vaccines published May 2, 2006.
